Scinovex
article Open Access

To compare efficacy of mifepristone and Ulipristal acetate in the management of uterine fibroids

Meeta GuptaNarita Jamwal

Abstract

Background: Uterine fibroids are one of the most common benign uterine tumors seen in females of reproductive age group. The present study was conducted to compare efficacy of Mifepristone and Ulipristal acetate in the management of symptomatic uterine fibroids. Materials & Methods: The present study was conducted on 80 women with diagnosis of uterine fibroid. Patients were divided into 2 groups of 40 each. Group I patients were given mifepristone 25 mg orally and group II patients received Ulipristal acetate 10 mg. Results: There were 28 patients in group I and 25 in group II with size less than 3 cm and 12 in group I and 15 in group II with size 3-5 cm. The difference was significant (P0.05). Conclusion: Authors found that both the agents can be used in management of women with uterine fibroids.

Uterine Myomas and TreatmentsEndometriosis Research and TreatmentUlipristal acetateMifepristoneUterine fibroidsMedicineGynecologyLeiomyomaUrologySurgeryResearch methodologyPregnancy
Citations
0
FWCI
0.00
field-weighted impact
References
10
Percentile
1%
vs. same field & year
Related articles
To compare efficacy of mifepristone and Ulipristal acetate in the management of uterine fibroids
International Journal of Clinical Obstetrics and Gynaecology · 2020 · 0 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

To compare efficacy of mifepristone and Ulipristal acetate in the management of uterine fibroids · Scinovex